Sodium Chloride Inhalation Solution, USP 0.9% FOR RESPIRATORY THERAPY 3 ml Sterile Unit Dose Vials | Sodium Chloride

Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional.

Sodium Chloride, USP 0.9% (0.027 mg per 1 mL)

Sterile, non-pyrogenic, preservative-free single-use vials for respiratory therapy. No bacteriostatic agent or other preservative added.

Intended for use in respiratory therapy or for tracheal or lavage.

Not for injection or in preparations to be used for injection.

To verify container integrity, squeeze the vial before use. Twist cap completely off vial, invert and squeeze prescribed volume.

Discard any unused portion of the contents of this single-use vial as well as any unused solution remaining in the nebulizer cup.

Keep out of reach of children.

Water for Injection, USP

Sodium Chloride Inhalation Solution, 0.9% is supplied in single-use plastic vials in the following configurations.

NDC 0487-9301-03 3 mL, 100 vials per carton

NDC 0487-9301-33 3 mL, 30 vials per carton/1 vial per foil pouch

Internal contents sterile. External surface of vial not sterile.

Store at controlled room temperature 15° to 30°C (59° to 86°F).

Manufactured By:

Nephron Pharmaceuticals Corporation

Orlando, FL 32811

1-800-443-4313

Principal Display – Carton (100 count)

Principal Display – Foil Pouch (30 individually wrapped vials)

Manufacturer

Nephron Pharmaceuticals Corporation

Active Ingredients

Source

U.S. National Library of Medicine
DailyMed
Last Updated: 31st of January 2012

Medications 2986 Associated Medications

S2
S2® Racepinephrine Inhalation Solution, USP 2.25% (Bronchodilator) FOR ORAL INHALATION ONLY 0.5 ml Sterile Unit-of-Use Vials
Sodium chloride
Preservative-Free 0.9% Sodium Chloride Injection, USP
Pulmozyme
Pulmozyme (dornase alfa)Inhalation Solution
Ipratropium bromide
Ipratropium Bromide Inhalation Solution, 0.02% FOR INHALATION USE ONLY – NOT FOR INJECTION
Primatene mist
Primatene MIST

Clinical Trials 3549 Associated Clinical Trials

Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis.
It is hypothesized that the inhalation of sodium pyruvate will reduce lung damage in patients with Cystic Fibrosis (CF) by its ability to reduce levels of toxic reactive oxygen and nitroge...
Dose-Finding, Safety, Pharmacodynamic Effect Study of Sodium Nitrite Inhalation Solution in Normal, Healthy Volunteers
This study is designed to investigate the safety and tolerability of AIR001 Inhalation Solution when administered under conditions of hypoxia and to identify dose levels of drug resulting...
Safety of Continuous Potassium Chloride Infusion in Critical Care
Patients in critical care often require supplemental potassium chloride if levels in their blood are below acceptable level. Common practice is to administer a single dose of potassium chl...
Safety and Efficacy Study of the Use of Sodium Pyruvate Bronchodilation in Asthmatics
Sodium pyruvate in sodium chloride solution will be delivered by nebulization to the lungs. It is believed that this administration will produce bronchodilation in asthmatics as determined...
Aztreonam for Inhalation Solution (AZLI) vs Tobramycin Inhalation Solution (TOBI®) in Patients With CF & P. Aeruginosa
The purpose of this study is to assess the comparative safety and effectiveness of Aztreonam for Inhalation Solution versus Tobramycin Nebuliser Solution in adult and pediatric patients wi...

PubMed Articles 18061 Associated PubMed Articles

Modify washing solutions in the process of deglycerolization in ACP 215 and storage at 4 degrees C in 0.9% sodium chloride in 24h.
BACKGROUND: The ACP 215 was a functional closed system for preparing glycerolized and deglycerolized RBCs, CSBT had approved the technique of long term storage glycerolized rare blood lower than -65 d...
Stability of polymyxin B sulfate diluted in 0.9% sodium chloride injection and stored at 4 or 25 degrees C.
PURPOSE: The stability of polymyxin B sulfate in infusion bags containing 0.9% sodium chloride injection stored at 4 and 25 degrees C was studied. METHODS: Seven manufacturing batches of polymyxin B f...
Derivation of physiological inhalation rates in children, adults, and elderly based on nighttime and daytime respiratory parameters.
The methodology developed in our previous studies ( Brochu et al. 2006a?c ) for the determination of physiological daily inhalation rates was improved by integrating into the calculation process, both...
Effects of acute dilutional hyponatremia on acid-base changes and electrolyte concentrations in rats with bilateral renal pedicle ligation.
Objective-To describe the effects of increasing the extracellular fluid (ECF) volume by approximately 20% on acid-base changes and electrolyte concentrations in anesthetized rats. Animals-18 adult mal...
The ADMIT series - Issues in Inhalation Therapy. 5) Inhaler selection in children with asthma.
Many children with asthma do not use their inhalers correctly and consequently gain little or no therapeutic benefit from the treatment. The focus of inhalation therapy should be on those inhalers whi...